Mutational signatures and mutable motifs in cancer genomes
暂无分享,去创建一个
Subhajyoti De | Anna R. Panchenko | Eugenia Poliakov | Igor B. Rogozin | Youri I. Pavlov | David N. Cooper | Alexander Goncearenco | Artem G. Lada | A. Panchenko | D. Cooper | S. De | I. Rogozin | A. Goncearenco | E. Poliakov | Y. Pavlov | A. G. Lada
[1] Leonid A. Mirny,et al. Tug-of-war between driver and passenger mutations in cancer and other adaptive processes , 2014, Proceedings of the National Academy of Sciences.
[2] Julian Gehring,et al. SomaticSignatures: inferring mutational signatures from single-nucleotide variants , 2014, bioRxiv.
[3] Valer Gotea,et al. Pan-cancer stratification of solid human epithelial tumors and cancer cell lines reveals commonalities and tissue-specific features of the CpG island methylator phenotype , 2015, Epigenetics & Chromatin.
[4] Alexey S Kondrashov,et al. Context of deletions and insertions in human coding sequences , 2004, Human mutation.
[5] Philip J. Farabaugh,et al. Molecular basis of base substitution hotspots in Escherichia coli , 1978, Nature.
[6] Eugene V Koonin,et al. Mutational hotspots in the TP53 gene and, possibly, other tumor suppressors evolve by positive selection , 2006, Biology Direct.
[7] Adam P Butler,et al. Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer , 2014, Nature Genetics.
[8] Mark Lee,et al. Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection , 2017, Cell.
[9] N A Kolchanov,et al. Somatic hypermutagenesis in immunoglobulin genes. III. Somatic mutations in the chicken light chain locus. , 1996, Biochimica et biophysica acta.
[10] C. Curtis,et al. A Big Bang model of human colorectal tumor growth , 2015, Nature Genetics.
[11] Arthur P. Grollman,et al. Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing , 2016, Proceedings of the National Academy of Sciences.
[12] J. Kench,et al. Whole genomes redefine the mutational landscape of pancreatic cancer , 2015, Nature.
[13] John Quackenbush,et al. A three-gene model to robustly identify breast cancer molecular subtypes. , 2012, Journal of the National Cancer Institute.
[14] Pingfang Liu,et al. DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification , 2017, Science.
[15] Ash A. Alizadeh,et al. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation , 2015, Proceedings of the National Academy of Sciences.
[16] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[17] X. Estivill,et al. Activating Mutations Cluster in the “Molecular Brake” Regions of Protein Kinases and Do Not Associate with Conserved or Catalytic Residues , 2014, Human mutation.
[18] David N Cooper,et al. Breakpoints of gross deletions coincide with non-B DNA conformations. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] Takashi Akasaka,et al. BCL6 breaks occur at different AID sequence motifs in Ig-BCL6 and non-Ig-BCL6 rearrangements. , 2013, Blood.
[20] M. Goodman,et al. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation , 2003, Nature.
[21] V. I. Mayorov,et al. Mutator effects and mutation signatures of editing deaminases produced in bacteria and yeast , 2011, Biochemistry (Moscow).
[22] L. Loeb,et al. Human Cancers Express a Mutator Phenotype: Hypothesis, Origin, and Consequences. , 2016, Cancer research.
[23] R. Wood,et al. DNA polymerases and cancer , 2011, Nature Reviews Cancer.
[24] M. Stratton,et al. Clock-like mutational processes in human somatic cells , 2015, Nature Genetics.
[25] Subhajyoti De,et al. Patterns of somatically acquired amplifications and deletions in apparently normal tissues of ovarian cancer patients. , 2014, Cell reports.
[26] David N. Cooper,et al. The CpG dinucleotide and human genetic disease , 1988, Human Genetics.
[27] L. Alexandrov,et al. Base changes in tumour DNA have the power to reveal the causes and evolution of cancer , 2016, Oncogene.
[28] A. Børresen-Dale,et al. Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.
[29] B W Glickman,et al. Mutational specificity of alkylating agents and the influence of DNA repair , 1990, Environmental and molecular mutagenesis.
[30] Z. Szallasi,et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.
[31] Trevor A Graham,et al. New paradigms in clonal evolution: punctuated equilibrium in cancer , 2016, The Journal of pathology.
[32] Benjamin A. Shoemaker,et al. Cancer Missense Mutations Alter Binding Properties of Proteins and Their Interaction Networks , 2013, PloS one.
[33] Shamil R. Sunyaev,et al. Impact of deleterious passenger mutations on cancer progression , 2012, Proceedings of the National Academy of Sciences.
[34] I. Rogozin,et al. Analysis of phylogenetically reconstructed mutational spectra in human mitochondrial DNA control region , 2002, Human Genetics.
[35] Yusuke Nakamura,et al. Cancer Precision Medicine: From Cancer Screening to Drug Selection and Personalized Immunotherapy. , 2017, Trends in pharmacological sciences.
[36] S. Benzer,et al. From the gene to behavior. , 1971, JAMA.
[37] A. Jackson,et al. The mutation rate and cancer. , 1998, Genetics.
[38] D. Brash. UV Signature Mutations , 2015, Photochemistry and photobiology.
[39] N A Kolchanov,et al. Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis. , 1992, Biochimica et biophysica acta.
[40] John A Tainer,et al. Translocation and deletion breakpoints in cancer genomes are associated with potential non-B DNA-forming sequences , 2016, Nucleic acids research.
[41] Roman Rouzier,et al. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy , 2005, Clinical Cancer Research.
[42] M. Stratton,et al. A census of amplified and overexpressed human cancer genes , 2010, Nature Reviews Cancer.
[43] M. Stratton,et al. High burden and pervasive positive selection of somatic mutations in normal human skin , 2015, Science.
[44] Steven A. Roberts,et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers , 2013, Nature Genetics.
[45] Toshiro Matsuda,et al. Somatic mutation hotspots correlate with DNA polymerase η error spectrum , 2001, Nature Immunology.
[46] David Tamborero,et al. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes , 2013, Bioinform..
[47] Takeshi Azuma,et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium , 2007, Nature Medicine.
[48] Ralph Scully,et al. Role of BRCA gene dysfunction in breast and ovarian cancer predisposition , 2000, Breast Cancer Research.
[49] M Krawczak,et al. Somatic spectrum of cancer‐associated single basepair substitutions in the TP53 gene is determined mainly by endogenous mechanisms of mutation and by selection , 1995, Human mutation.
[50] M Krawczak,et al. Neighboring-nucleotide effects on the rates of germ-line single-base-pair substitution in human genes. , 1998, American journal of human genetics.
[51] F J Ayala,et al. A new method for characterizing replacement rate variation in molecular sequences. Application of the Fourier and wavelet models to Drosophila and mammalian proteins. , 2000, Genetics.
[52] Gennaro Ciliberto,et al. Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy? , 2016, Cancer treatment reviews.
[53] Reuben S Harris,et al. Pillars article: AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature. 2002. 418: 99-103. , 2015, Journal of immunology.
[54] P. Peltomäki,et al. DNA mismatch repair and cancer. , 2001, Mutation research.
[55] M. Stratton,et al. Mutational signatures: the patterns of somatic mutations hidden in cancer genomes , 2014, Current opinion in genetics & development.
[56] B. Preston,et al. DNA replication fidelity and cancer. , 2010, Seminars in cancer biology.
[57] W. H. Day,et al. Threshold consensus methods for molecular sequences. , 1992, Journal of theoretical biology.
[58] T Ishikawa,et al. Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[59] M J O'Hare,et al. Linking gene expression patterns to therapeutic groups in breast cancer. , 2000, Cancer research.
[60] R. Kolodner,et al. Identification of mismatch repair genes and their role in the development of cancer. , 1995, Current opinion in genetics & development.
[61] I. Rogozin,et al. AID/APOBEC cytosine deaminase induces genome-wide kataegis , 2012, Biology Direct.
[62] Eugene V Koonin,et al. Signs of positive selection of somatic mutations in human cancers detected by EST sequence analysis , 2006, BMC Cancer.
[63] P. Campbell,et al. Somatic mutation in cancer and normal cells , 2015, Science.
[64] Luciano Milanesi,et al. Computational analysis of mutation spectra , 2003, Briefings Bioinform..
[65] Florian Markowetz,et al. A saltationist theory of cancer evolution , 2016, Nature Genetics.
[66] Steven A Roberts,et al. Clustered and genome‐wide transient mutagenesis in human cancers: Hypermutation without permanent mutators or loss of fitness , 2014, BioEssays : news and reviews in molecular, cellular and developmental biology.
[67] H. Sebastian Seung,et al. Learning the parts of objects by non-negative matrix factorization , 1999, Nature.
[68] Giovanni Parmigiani,et al. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation , 2013, Proceedings of the National Academy of Sciences.
[69] Christophe Badie,et al. Mutational signatures of ionizing radiation in second malignancies , 2016, Nature Communications.
[70] T. Andrews,et al. Comparison of predicted and actual consequences of missense mutations , 2015, Proceedings of the National Academy of Sciences.
[71] S. Gabriel,et al. Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.
[72] Robert A Beckman,et al. Genetic instability in cancer: theory and experiment. , 2005, Seminars in cancer biology.
[73] Adam Auton,et al. Age-related somatic mutations in the cancer genome , 2015, Oncotarget.
[74] Hans Clevers,et al. Tissue-specific mutation accumulation in human adult stem cells during life , 2016, Nature.
[75] Igor B. Rogozin,et al. Regression trees for analysis of mutational spectra in nucleotide sequences , 1999, Bioinform..
[76] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[77] N. A. Temiz,et al. Evidence for APOBEC3B mutagenesis in multiple human cancers , 2013, Nature Genetics.
[78] Marc J. Williams,et al. Identification of neutral tumor evolution across cancer types , 2016, Nature Genetics.
[79] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[80] B. Taylor,et al. deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution , 2016, Genome Biology.
[81] A. Panchenko,et al. Oncogenic potential is related to activating effect of cancer single and double somatic mutations in receptor tyrosine kinases , 2012, Human mutation.
[82] Puay Hoon Tan,et al. Conservation of Breast Cancer Molecular Subtypes and Transcriptional Patterns of Tumor Progression Across Distinct Ethnic Populations , 2004, Clinical Cancer Research.
[83] Reuben S Harris,et al. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. , 2004, Journal of molecular biology.
[84] Gad Getz,et al. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers , 2015, Nature Genetics.
[85] H. Ohtsuki,et al. Accumulation of driver and passenger mutations during tumor progression , 2009, Proceedings of the National Academy of Sciences.
[86] S. Gabriel,et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.
[87] Ralph H. Hruban,et al. Genomic Landscapes of Pancreatic Neoplasia , 2015, Journal of pathology and translational medicine.
[88] Subhajyoti De,et al. Somatic mosaicism in healthy human tissues. , 2011, Trends in genetics : TIG.
[89] R. Prayson,et al. Mutational Heterogeneity in Human Cancers : Origin and Consequences , 2010 .
[90] Cynthia J. Sakofsky,et al. Break-induced replication is a source of mutation clusters underlying kataegis. , 2014, Cell reports.
[91] M. Stratton,et al. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis , 2013, eLife.
[92] David Managadze,et al. Generalized Portrait of Cancer Metabolic Pathways Inferred from a List of Genes Overexpressed in Cancer , 2014, Genetics research international.
[93] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[94] M. Neuberger,et al. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification , 2002, Nature.
[95] Pablo Tamayo,et al. Metagenes and molecular pattern discovery using matrix factorization , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[96] C. Plass,et al. Pan-cancer patterns of DNA methylation , 2014, Genome Medicine.
[97] Ian Tomlinson,et al. A panoply of errors: polymerase proofreading domain mutations in cancer , 2016, Nature Reviews Cancer.
[98] N. A. Temiz,et al. APOBEC3B is an enzymatic source of mutation in breast cancer , 2013, Nature.
[99] C. Rada,et al. Active RNAP pre-initiation sites are highly mutated by cytidine deaminases in yeast, with AID targeting small RNA genes , 2014, eLife.
[100] Xavier Castells,et al. MutSpec: a Galaxy toolbox for streamlined analyses of somatic mutation spectra in human and mouse cancer genomes , 2016, BMC Bioinformatics.
[101] Steven A. Roberts,et al. Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. , 2012, Molecular cell.
[102] M. Stratton,et al. Mutational signatures associated with tobacco smoking in human cancer , 2016, Science.
[103] M. J. van de Vijver,et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. , 2006, Journal of the National Cancer Institute.
[104] Sushma Sharma,et al. Colon cancer-associated mutator DNA polymerase δ variant causes expansion of dNTP pools increasing its own infidelity , 2015, Proceedings of the National Academy of Sciences.
[105] J. Herman,et al. CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[106] Igor B. Rogozin,et al. Disruption of Transcriptional Coactivator Sub1 Leads to Genome-Wide Re-distribution of Clustered Mutations Induced by APOBEC in Active Yeast Genes , 2015, PLoS genetics.
[107] Tirso Pons,et al. Structure-PPi: a module for the annotation of cancer-related single-nucleotide variants at protein–protein interfaces , 2015, Bioinform..
[108] M. McCarthy,et al. Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.
[109] A. Nobel,et al. The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.
[110] Igor B. Rogozin,et al. Genome-Wide Mutation Avalanches Induced in Diploid Yeast Cells by a Base Analog or an APOBEC Deaminase , 2013, PLoS genetics.
[111] John M Coffin,et al. Virology. Weapons of mutational destruction. , 2003, Science.
[112] Jiajia Chen,et al. Deciphering oncogenic drivers: from single genes to integrated pathways , 2015, Briefings Bioinform..
[113] T B Kepler,et al. Statistical inference of sequence-dependent mutation rates. , 2001, Current opinion in genetics & development.
[114] Chikahide Masutani,et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η , 1999, Nature.
[115] P. Gearhart,et al. Antibody diversification caused by disrupted mismatch repair and promiscuous DNA polymerases. , 2016, DNA repair.
[116] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[117] W. H. Day,et al. Critical comparison of consensus methods for molecular sequences. , 1992, Nucleic acids research.
[118] T. Kunkel,et al. Considering the cancer consequences of altered DNA polymerase function. , 2003, Cancer cell.
[119] C. Févotte,et al. Automatic Relevance Determination in Nonnegative Matrix Factorization with the-Divergence , 2011 .
[120] I. Rogozin,et al. Modulation of mutagenesis in eukaryotes by DNA replication fork dynamics and quality of nucleotide pools , 2012, Environmental and molecular mutagenesis.
[121] Satoru Miyano,et al. Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution , 2016, PLoS genetics.
[122] C. Sotiriou,et al. Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology , 2014, BMC Genomics.
[123] J. Rowley,et al. Chromosome translocations: dangerous liaisons revisited , 2001, Nature Reviews Cancer.
[124] P. Laird,et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. , 2012, Genome research.
[125] Ke Ma,et al. Balancing Protein Stability and Activity in Cancer: A New Approach for Identifying Driver Mutations Affecting CBL Ubiquitin Ligase Activation. , 2016, Cancer research.
[126] P. A. Futreal,et al. Emerging patterns of somatic mutations in cancer , 2013, Nature Reviews Genetics.
[127] Subhajyoti De,et al. Activation induced deaminase mutational signature overlaps with CpG methylation sites in follicular lymphoma and other cancers , 2016, Scientific Reports.
[128] K Bebenek,et al. Error rate and specificity of human and murine DNA polymerase eta. , 2001, Journal of molecular biology.
[129] Marcel J T Reinders,et al. Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis , 2014, Genome research.
[130] E. Mardis,et al. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay , 2015, BMC Medical Genomics.
[131] M. Stratton,et al. Deciphering Signatures of Mutational Processes Operative in Human Cancer , 2013, Cell reports.
[132] David N Cooper,et al. On the sequence‐directed nature of human gene mutation: The role of genomic architecture and the local DNA sequence environment in mediating gene mutations underlying human inherited disease , 2011, Human mutation.
[133] Jose M. Duarte,et al. The structural impact of cancer-associated missense mutations in oncogenes and tumor suppressors , 2011, Molecular Cancer.
[134] R. Lewontin,et al. Locating regions of differential variability in DNA and protein sequences. , 1999, Genetics.
[135] John M. Coffin,et al. Weapons of Mutational Destruction , 2003, Science.
[136] Bert Vogelstein,et al. DETECTION OF CIRCULATING TUMOR DNA IN EARLY AND LATE STAGE HUMAN MALIGNANCIES , 2014 .
[137] Xuemei Lu,et al. Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution , 2015, Proceedings of the National Academy of Sciences.
[138] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[139] Roland Arnold,et al. Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers , 2015, Nature Genetics.
[140] Pei-Yau Lung,et al. Personalized chemotherapy selection for breast cancer using gene expression profiles , 2017, Scientific Reports.
[141] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[142] T. Kunkel,et al. Unique Error Signature of the Four-subunit Yeast DNA Polymerase ϵ* , 2003, Journal of Biological Chemistry.
[143] M. Nowak,et al. Only three driver gene mutations are required for the development of lung and colorectal cancers , 2014, Proceedings of the National Academy of Sciences.
[144] Reuben S Harris,et al. Immunity through DNA deamination. , 2003, Trends in biochemical sciences.
[145] Tony M Mertz,et al. A cancer-associated DNA polymerase δ variant modeled in yeast causes a catastrophic increase in genomic instability , 2009, Proceedings of the National Academy of Sciences.
[146] T. D. Schneider,et al. Quantitative analysis of the relationship between nucleotide sequence and functional activity. , 1986, Nucleic acids research.
[147] R. Nussinov,et al. 'Latent drivers' expand the cancer mutational landscape. , 2015, Current opinion in structural biology.
[148] Matthew Mort,et al. mutation3D: Cancer Gene Prediction Through Atomic Clustering of Coding Variants in the Structural Proteome , 2016, Human mutation.
[149] Subhajyoti De,et al. The landscape of somatic mutations in protein coding genes in apparently benign human tissues carries signatures of relaxed purifying selection , 2016, Nucleic acids research.
[150] Humam Kadara,et al. Field cancerization in non-small cell lung cancer: implications in disease pathogenesis. , 2012, Proceedings of the American Thoracic Society.
[151] P O'Neill,et al. Securing genome stability by orchestrating DNA repair: removal of radiation-induced clustered lesions in DNA. , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[152] D. Bogenhagen,et al. Clusters of point mutations are found exclusively around rearranged antibody variable genes. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[153] L. Loeb,et al. Errors in DNA replication as a basis of malignant changes. , 1974, Cancer research.
[154] Funda Meric-Bernstam,et al. Punctuated Copy Number Evolution and Clonal Stasis in Triple-Negative Breast Cancer , 2016, Nature Genetics.
[155] I. Rogozin,et al. Theoretical analysis of mutation hotspots and their DNA sequence context specificity. , 2003, Mutation research.
[156] Isidro Cortes-Ciriano,et al. The Impact of Environmental and Endogenous Damage on Somatic Mutation Load in Human Skin Fibroblasts , 2016, PLoS genetics.
[157] Martin A. Nowak,et al. Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution , 2016, PLoS Comput. Biol..
[158] Kin Chan,et al. Clusters of Multiple Mutations: Incidence and Molecular Mechanisms. , 2015, Annual review of genetics.
[159] Michael Huemer,et al. AID/APOBEC deaminases and cancer , 2015, Oncoscience.
[160] Bin Zhu,et al. Edinburgh Research Explorer Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors , 2022 .
[161] Alan Ashworth,et al. Translating cancer research into targeted therapeutics , 2010, Nature.
[162] M. Wabl,et al. Critical test of hot spot motifs for immunoglobulin hypermutation , 1997, European journal of immunology.
[163] Dmitry A. Gordenin,et al. Hypermutation in human cancer genomes: footprints and mechanisms , 2014, Nature Reviews Cancer.
[164] Brent S. Pedersen,et al. Signatures of accelerated somatic evolution in gene promoters in multiple cancer types , 2015, Nucleic acids research.
[165] M. D. Topal,et al. O6-methylguanine mutation and repair is nonuniform. Selection for DNA most interactive with O6-methylguanine. , 1986, The Journal of biological chemistry.
[166] Vincent Y. F. Tan,et al. Automatic Relevance Determination in Nonnegative Matrix Factorization with the /spl beta/-Divergence , 2011, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[167] M. Stratton,et al. The cancer genome , 2009, Nature.